vs
Side-by-side financial comparison of Atlanta Braves Holdings, Inc. (BATRA) and STEM, INC. (STEM). Click either name above to swap in a different company.
Atlanta Braves Holdings, Inc. is the larger business by last-quarter revenue ($61.3M vs $47.1M, roughly 1.3× STEM, INC.). STEM, INC. runs the higher net margin — -33.9% vs -67.6%, a 33.7% gap on every dollar of revenue. On growth, Atlanta Braves Holdings, Inc. posted the faster year-over-year revenue change (17.6% vs -15.6%). Over the past eight quarters, STEM, INC.'s revenue compounded faster (36.1% CAGR vs -52.5%).
Atlanta Braves Holdings, Inc. is a sports and entertainment holding company that owns and operates the Atlanta Braves MLB franchise. It also manages adjacent mixed-use real estate, live events, merchandise sales, and media operations, serving fans across the U.S. Southeast and global baseball audiences.
StemCells, Inc. is a public biopharmaceutical company headquartered in Newark, California, that is developing purified human neural stem cells (HuCNS-SCs) in the hopes of treating central nervous system disorders and paralysis. StemCells' HuCNS-SCs have the ability to differentiate into the three main types of cells found in the central nervous system: neurons, astrocytes and oligodendrocytes.
BATRA vs STEM — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | ||
|---|---|---|
| Revenue | $61.3M | $47.1M |
| Net Profit | $-41.4M | $-16.0M |
| Gross Margin | — | 48.9% |
| Operating Margin | -81.2% | -17.7% |
| Net Margin | -67.6% | -33.9% |
| Revenue YoY | 17.6% | -15.6% |
| Net Profit YoY | -116.7% | 68.8% |
| EPS (diluted) | $-0.64 | $-4.40 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $61.3M | $47.1M | ||
| Q3 25 | $311.5M | $38.2M | ||
| Q2 25 | $312.4M | $38.4M | ||
| Q1 25 | $47.2M | $32.5M | ||
| Q4 24 | $52.1M | $55.8M | ||
| Q3 24 | $290.7M | $29.3M | ||
| Q2 24 | $282.9M | $34.0M | ||
| Q1 24 | — | $25.5M |
| Q4 25 | $-41.4M | $-16.0M | ||
| Q3 25 | $30.0M | $-23.8M | ||
| Q2 25 | $29.5M | $202.5M | ||
| Q1 25 | $-41.4M | $-25.0M | ||
| Q4 24 | $-19.1M | $-51.1M | ||
| Q3 24 | $10.0M | $-148.3M | ||
| Q2 24 | $29.1M | $-582.3M | ||
| Q1 24 | — | $-72.3M |
| Q4 25 | — | 48.9% | ||
| Q3 25 | — | 35.5% | ||
| Q2 25 | — | 33.4% | ||
| Q1 25 | — | 32.4% | ||
| Q4 24 | — | -4.4% | ||
| Q3 24 | — | 21.2% | ||
| Q2 24 | — | 27.6% | ||
| Q1 24 | — | -95.0% |
| Q4 25 | -81.2% | -17.7% | ||
| Q3 25 | 12.5% | -33.6% | ||
| Q2 25 | 13.4% | -34.8% | ||
| Q1 25 | -94.2% | -65.0% | ||
| Q4 24 | -35.8% | -84.4% | ||
| Q3 24 | 2.2% | -493.2% | ||
| Q2 24 | 8.8% | -1705.5% | ||
| Q1 24 | — | -267.0% |
| Q4 25 | -67.6% | -33.9% | ||
| Q3 25 | 9.6% | -62.2% | ||
| Q2 25 | 9.4% | 527.8% | ||
| Q1 25 | -87.7% | -76.9% | ||
| Q4 24 | -36.7% | -91.6% | ||
| Q3 24 | 3.4% | -506.3% | ||
| Q2 24 | 10.3% | -1712.6% | ||
| Q1 24 | — | -283.9% |
| Q4 25 | $-0.64 | $-4.40 | ||
| Q3 25 | $0.47 | $-2.84 | ||
| Q2 25 | $0.46 | $-1.79 | ||
| Q1 25 | $-0.66 | $-0.15 | ||
| Q4 24 | $-0.29 | $-15.29 | ||
| Q3 24 | $0.16 | $-18.24 | ||
| Q2 24 | $0.46 | $-71.81 | ||
| Q1 24 | — | $-0.46 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | ||
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $99.9M | $48.9M |
| Total DebtLower is stronger | $738.6M | — |
| Stockholders' EquityBook value | $526.0M | $-249.4M |
| Total Assets | $1.6B | $308.9M |
| Debt / EquityLower = less leverage | 1.40× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $99.9M | $48.9M | ||
| Q3 25 | $82.2M | $43.1M | ||
| Q2 25 | $96.2M | $40.8M | ||
| Q1 25 | $244.7M | $58.6M | ||
| Q4 24 | $110.1M | $56.3M | ||
| Q3 24 | $100.9M | $75.4M | ||
| Q2 24 | $121.2M | $89.6M | ||
| Q1 24 | — | $112.8M |
| Q4 25 | $738.6M | — | ||
| Q3 25 | $759.9M | — | ||
| Q2 25 | $703.1M | — | ||
| Q1 25 | $699.5M | — | ||
| Q4 24 | $617.1M | — | ||
| Q3 24 | $640.1M | — | ||
| Q2 24 | $600.0M | — | ||
| Q1 24 | — | — |
| Q4 25 | $526.0M | $-249.4M | ||
| Q3 25 | $560.3M | $-235.7M | ||
| Q2 25 | $522.8M | $-214.1M | ||
| Q1 25 | $486.1M | $-417.5M | ||
| Q4 24 | $524.2M | $-398.4M | ||
| Q3 24 | $530.4M | $-344.1M | ||
| Q2 24 | $512.7M | $-203.2M | ||
| Q1 24 | — | $371.6M |
| Q4 25 | $1.6B | $308.9M | ||
| Q3 25 | $1.7B | $362.6M | ||
| Q2 25 | $1.7B | $379.2M | ||
| Q1 25 | $1.7B | $405.1M | ||
| Q4 24 | $1.5B | $437.4M | ||
| Q3 24 | $1.6B | $537.8M | ||
| Q2 24 | $1.6B | $691.5M | ||
| Q1 24 | — | $1.3B |
| Q4 25 | 1.40× | — | ||
| Q3 25 | 1.36× | — | ||
| Q2 25 | 1.34× | — | ||
| Q1 25 | 1.44× | — | ||
| Q4 24 | 1.18× | — | ||
| Q3 24 | 1.21× | — | ||
| Q2 24 | 1.17× | — | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | ||
|---|---|---|
| Operating Cash FlowLast quarter | $26.4M | $8.2M |
| Free Cash FlowOCF − Capex | — | — |
| FCF MarginFCF / Revenue | — | — |
| Capex IntensityCapex / Revenue | 0.0% | — |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $26.4M | $8.2M | ||
| Q3 25 | $-88.8M | $11.4M | ||
| Q2 25 | $-8.1M | $-21.3M | ||
| Q1 25 | $95.8M | $8.5M | ||
| Q4 24 | $28.9M | $-14.7M | ||
| Q3 24 | $-69.0M | $-9.4M | ||
| Q2 24 | $-34.3M | $-11.9M | ||
| Q1 24 | — | $-621.0K |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | $-82.3M | — | ||
| Q1 25 | $76.3M | — | ||
| Q4 24 | $16.8M | — | ||
| Q3 24 | $-85.5M | — | ||
| Q2 24 | $-64.1M | — | ||
| Q1 24 | — | — |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | -26.3% | — | ||
| Q1 25 | 161.5% | — | ||
| Q4 24 | 32.3% | — | ||
| Q3 24 | -29.4% | — | ||
| Q2 24 | -22.7% | — | ||
| Q1 24 | — | — |
| Q4 25 | 0.0% | — | ||
| Q3 25 | 0.0% | — | ||
| Q2 25 | 23.7% | — | ||
| Q1 25 | 41.3% | — | ||
| Q4 24 | 23.2% | — | ||
| Q3 24 | 5.7% | — | ||
| Q2 24 | 10.5% | — | ||
| Q1 24 | — | — |
| Q4 25 | — | — | ||
| Q3 25 | -2.96× | — | ||
| Q2 25 | -0.28× | -0.11× | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | -6.89× | — | ||
| Q2 24 | -1.18× | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
BATRA
| Baseball | $34.8M | 57% |
| Mixed Use Development Segment | $26.5M | 43% |
STEM
Segment breakdown not available.